Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients

Background: The effect of direct oral anticoagulants (DOAC) on laboratory tests dependent on the production of their targets, factor IIa and factor Xa, is a well-known problem and can cause both false positive and negative results. In particular, the situation in patients who develop lupus anticoagu...

詳細記述

書誌詳細

出版年:	Diagnostics
主要な著者:	Jana Úlehlová, Barbora Piskláková, Eliška Ivanovová, Jana Procházková, Pavla Bradáčová, Aleš Kvasnička, David Friedecký, Luděk Slavík
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-11-01
主題:	dabigatran rivaroxaban apixaban DOAC-Stop liquid chromatography tandem mass spectrometry
オンライン･アクセス:	https://www.mdpi.com/2075-4418/11/11/2027